Indications
Treatment of tenosynovial giant cell tumour.
Composition
- Active substance
- pexidartinib
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Turalio
- Active substance
- pexidartinib
- ATC code
- L01XE
- Therapeutic area
- Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular
- Marketing authorisation holder
- Daiichi Sankyo Europe GmbH
- Status
- Refused
- Refused
- 28 Oct 2020
- EMA product number